GLP-1 receptor agonists, SGLT2 inhibitors and noncardiovascular mortality in type 2 diabetes: Insights from a meta-analysis
Mainak Banerjee, Rimesh Pal, Indira Maisnam, Satinath Mukhopadhyay
Topics & Concepts
MedicineInternal medicineType 2 diabetesMeta-analysisPlaceboRelative riskSubgroup analysisHazard ratioRandomizationRandomized controlled trialDiabetes mellitusEndocrinologyConfidence intervalPathologyAlternative medicineDiabetes Treatment and ManagementHeart Failure Treatment and ManagementHyperglycemia and glycemic control in critically ill and hospitalized patients